VS3 Medical

Executive Summary

VS3 Medical is a privately held medical device company based in San Diego, developing an investigational stent system for symptomatic venous sinus stenosis—a condition where impaired brain venous drainage causes pulsatile tinnitus, debilitating headaches, and other neurological symptoms. The VS3 Medical Stent System is designed to address the unique anatomical challenges of the dural venous sinuses, offering a potential therapeutic option for patients who currently have limited treatment alternatives. Founded in 2020, the company operates in the neurovascular intervention space and aims to improve quality of life for patients suffering from this underdiagnosed condition. While still in early stages, its focused approach on a specific mechanical pathology positions it as a niche player in the medical device landscape. The company has not yet disclosed funding rounds or valuation, indicating it may be pre-revenue and seeking capital to advance its pipeline. VS3 Medical's success hinges on clinical validation of its stent technology, regulatory navigation, and securing partnerships or financing to support pivotal trials. With growing awareness of venous sinus stenosis as a cause of secondary headaches and tinnitus, the market opportunity could expand significantly if clinical outcomes prove favorable.

Upcoming Catalysts (preview)

• Q2 2026First-in-human clinical trial initiation or results70% success
• Q3 2026Series A or seed funding round announcement60% success
• Q4 2026FDA IDE approval or breakthrough device designation50% success